Nuproxa Group Appoints Dr. Goetz Gotterbarm as CEO, ushering in a New Era

Nuproxa Group, a distinguished player in the natural animal nutrition additives and complementary feeds industry, proudly unveils a significant leadership transition. Effective January 1st, 2024, Dr. Goetz Gotterbarm assumes the role of Chief Executive Officer, succeeding the esteemed founder, Mr. Mathias Huber.

Strategic Leadership Transition: Nuproxa Group welcomes Dr. Goetz Gotterbarm as its new CEO, leveraging his impressive 30-year track record in the animal nutrition additives industry. His appointment signals a strategic move to guide the company through its next phase of growth and innovation.

Experience, Values, and Vision: Dr. Gotterbarm’s extensive experience, shared values, and aligned vision position him as an ideal leader to uphold Nuproxa’s commitment to excellence in natural animal nutrition. The leadership transition ensures a seamless continuation of the company’s dedication to quality.

Founder’s Continued Contribution: Mr. Mathias Huber, the visionary founder, steps down as CEO while assuming the roles of Chairman of the Board and Strategic Advisor. His continued involvement underscores a commitment to the ongoing success of Nuproxa.

Dr. Gotterbarm’s Vision for the Future: In his new capacity, Dr. Gotterbarm expresses gratitude for the confidence shareholders have placed in him. He shares insights on Nuproxa’s ongoing expansion, emphasizing preparedness for the challenges of a dynamic competitive and regulatory landscape.

The confidence of the shareholders in entrusting me with the responsibility to lead Nuproxa Group through the upcoming challenging years is deeply appreciated. Nuproxa is currently undergoing structural and geographic expansion, navigating a complex competitive and regulatory landscape. With recent successes in weathering challenges, we are well-prepared for the future.”Dr. Gotterbarm states.

Anticipating Success Under New Leadership: As Nuproxa embarks on this new chapter, the company anticipates continued success and growth under Dr. Gotterbarm’s leadership. Confidence abounds that Nuproxa will thrive in the evolving industry landscape, and the company extends gratitude to valued customers and suppliers for their ongoing partnership.

Media Contact: For media inquiries, please contact: Carlos Varanda, Head of Corporate Communication, Nuproxa Group Email: carlos.varanda@nuproxa.ch